HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Follicular dendritic cell sarcoma of the neck: report of a case treated by surgical excision and COP plus (PEG)-liposomal doxorubicin.

AbstractBACKGROUND:
Follicular dendritic cell (FDC) sarcoma is a rare neoplasm arising in lymph nodes but also in extranodal sites from accessory cells of the immune system that are essential for the function of antigen presentation and germinal center reaction regulation. FDC sarcoma has a significant recurrent and metastatic potential and for these reason it should be viewed as an intermediate grade malignancy.
METHODS:
We report the case of a 49-year old woman patient who showed persistent, enlarged, hard, cervical lymph node. The most common histologic feature was the presence of oval to spindle cells with elongated nuclei, vesicular or stippled chromatin and scant eosinophilic cytoplasm. Immunohistochemically, tumor cells were diffusely positive for follicular dendritic cell markers CD21, CD23 and negative for cytokeratin.The patient after complete excision of the lymph node underwent five courses of adjuvant chemotherapy with COP plus PEG-liposomal doxorubicin, considering the propensity of the tumor to metastasize.
RESULTS:
No hematological or cardiac toxicity were registered and among the other extra hematological effects only transitory palmar erythrodysesthesia is worthy of mention. After a follow up of 5 years the patient is alive and in CR.
CONCLUSION:
These results suggest that this therapeutic modality may be useful in the management of FDC sarcoma.
AuthorsFrancesco Pisani, Mirella Marino, Steno Sentinelli, Maria Concetta Petti
JournalJournal of experimental & clinical cancer research : CR (J Exp Clin Cancer Res) Vol. 27 Pg. 33 (Sep 02 2008) ISSN: 1756-9966 [Electronic] England
PMID18761751 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antibiotics, Antineoplastic
  • Receptors, Complement 3d
  • Receptors, IgE
  • Doxorubicin
Topics
  • Antibiotics, Antineoplastic (therapeutic use)
  • Chemotherapy, Adjuvant
  • Dendritic Cell Sarcoma, Follicular (drug therapy, surgery, therapy)
  • Doxorubicin (therapeutic use)
  • Female
  • Head and Neck Neoplasms (drug therapy, surgery, therapy)
  • Humans
  • Lymph Nodes (pathology)
  • Middle Aged
  • Receptors, Complement 3d (immunology)
  • Receptors, IgE (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: